The first transformation of an existing Bulgarian capital company into a company with variable capital – a recently adopted by the legislator new form of company – is a already a fact. While the general expectations are that this new form of company is available for original incorporation and transformation is expected after these cease to be start-ups, it may be also appropriate for reshaping the business opportunities of already incorporated companies, eligible under the law. Our client Praeva Biotech, formerly wholly owned limited liability company, will continue to develop its business in the area of biotech innovations by making use of the advantages, provided for a company with variable capital. This project was completed primarily by Ina Raikova from Spasov & Bratanov.

 

Date: March 2025

Source: Spasov & Bratanov Lawyers’ Partnership 

 

More Posts

In proceedings concerning claims for non-pecuniary damages to an individual arising from a publication, Spasov & Bratanov Law Firm successfully defended its client, a Maltese media company and publisher of

Read More »

THE EU AI ACT: KEY OBLIGATIONS TAKING EFFECT AS OF AUGUST 2ND 2026   Introduction Recognizing both the opportunities and the risks associated with the rapid development of artificial intelligence

Read More »

Spasov & Bratanov successfuly defended the right of a managing director to request his own deletion from the Commercial Register Spasov & Bratanov successfully advised and represented an individual in

Read More »

Welcoming Veronika Stefanova to Spasov & Bratanov We are delighted to welcome Veronika Stefanova to our team as an Associate. Veronika graduated magna cum laude from Sofia University “St. Kliment

Read More »

Share: